Chemical engineers find that arrays of carbon nanotubes can detect flaws in drugs and help improve production
MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs — especially those based on antibodies — more safely and efficiently.
Using these sensors, the researchers were able to characterize variations in the binding strength of antibody drugs, which hold promise for treating cancer and other diseases. They also used the sensors to monitor the structure of antibody molecules, including whether they contain a chain of sugars that interferes with proper function.
“This could help pharmaceutical companies figure out why certain drug formulations work better than others, and may help improve their effectiveness,” says Michael Strano, an MIT professor of chemical engineering and senior author of a recent paper describing the sensors in the journal ACS Nano.
The team also demonstrated how nanosensor arrays could be used to determine which cells in a population of genetically engineered, drug-producing cells are the most productive or desirable, Strano says.
Lead author of the paper is Nigel Reuel, a graduate student in Strano’s lab. The labs of MIT faculty members Krystyn Van Vliet, Christopher Love and Dane Wittrup also contributed, along with scientists from Novartis.
Testing drug strength
Strano and other scientists have previously shown that tiny, nanometer-sized sensors, such as carbon nanotubes, offer a powerful way to detect minute quantities of a substance. Carbon nanotubes are 50,000 times thinner than a human hair, and they can bind to proteins that recognize a specific target molecule. When the target is present, it alters the fluorescent signal produced by the nanotube in a way that scientists can detect.
Some researchers are trying to exploit large arrays of nanosensors, such as carbon nanotubes or semiconducting nanowires, each customized for a different target molecule, to detect many different targets at once. In the new study, Strano and his colleagues wanted to explore unique properties that emerge from large arrays of sensors that all detect the same thing.
The first feature they discovered, through mathematical modeling and experimentation, is that uniform arrays can measure the distribution in binding strength of complex proteins such as antibodies. Antibodies are naturally occurring molecules that play a key role in the body’s ability to recognize and defend against foreign invaders. In recent years, scientists have been developing antibodies to treat disease, particularly cancer. When those antibodies bind to proteins found on cancer cells, they stimulate the body’s own immune system to attack the tumor.
For antibody drugs to be effective, they must strongly bind their target. However, the manufacturing process, which relies on nonhuman, engineered cells, does not always generate consistent, uniformly binding batches of antibodies.
Currently, drug companies use time-consuming and expensive analytical processes to test each batch and make sure it meets the regulatory standards for effectiveness. However, the new MIT sensor could make this process much faster, allowing researchers to not only better monitor and control production, but also to fine-tune the manufacturing process to generate a more consistent product.
“You could use the technology to reject batches, but ideally you’d want to use it in your upstream process development to better define culture conditions, so then you wouldn’t produce spurious lots,” Reuel says.
Measuring weak interactions
Another useful trait of such sensors is their ability to measure very weak binding interactions, which could also help with antibody drug manufacturing.
The Latest Bing News on:
Nanoscale sensors
- CEA-Leti Selected to Coordinate Two EU Projects for Developing ‘First-Class’ 6G Capabilities and Contributing to Standardizationon April 26, 2024 at 9:32 am
GRENOBLE, France – April 25, 2024 – As part of the European Union’s drive to support a multifaceted approach to addressing 6G challenges and promises, CEA-Leti has been chosen to coordinate two ...
- Failure Analysis Equipment Market To Reach USD 8.7 Billion By 2032 | DataHorizzon Researchon April 26, 2024 at 1:30 am
The failure analysis equipment market size was valued at USD 4.5 Billion in 2022 and is expected to be valued at USD 8.7 Billion by 2032 at a CAGR of 6.8%.
- Mitsubishi and Denka to form JV for production of fullereneson April 25, 2024 at 1:19 pm
Mitsubishi Corp. (MC; Tokyo) and Denka Company Ltd. (Denka) have signed joint-venture (JV) agreement in the business of fullerenes, carbon molecules that ...
- Sound and vision: synchrotron insights illuminate crystal nucleation and growthon April 24, 2024 at 7:44 am
Curiosity-driven research using low-power ultrasound fields to investigate the fundamental physics of crystal nucleation – the formation of crystal nuclei and “embryos” in the liquid or solution phase ...
- MC and Denka Sign J/V Agreement in Fullerene Businesson April 24, 2024 at 1:02 am
Mitsubishi Corporation (MC) and Denka Company Limited (Denka) are pleased to announce our signing of a joint-venture agreement in the business of fullerenes, carbon molecules that form the base of ...
- Diamond-based quantum sensing microscope offers effective approach for quantifying cellular forceson April 22, 2024 at 5:56 am
Cells rely on constant interplay and information exchange with their micro-environment to ensure their survival and perform biological functions. Hence, precise quantification of tiny cellular ...
- Using Gold Luminescence to Probe Nanoscale Processeson April 21, 2024 at 5:00 pm
Electrons are frequently used as probes to characterize electronic processes, such as those in solar cells, because their behavior at the nanoscale when they absorb and re-emit light can reveal a ...
- Tiny Scale, Massive Impact: Firm Commercializing Groundbreaking Research at UAon April 19, 2024 at 1:18 pm
The company tagline — tiny scale, massive impact — effectively conveys the concept behind the commercialization of ...
- New iPhone 16 Camera Treatment May Put an End to Lens Flareon April 15, 2024 at 3:01 pm
According to the latest iPhone 16 Pro supply chain rumor, Apple has been testing new anti-reflective optical coating technologies for its iPhone cameras to help eliminate lens flares and artifacts ...
- Advancing Quantum Technologies with Magnetic “Butterfly”on April 15, 2024 at 8:56 am
Reviewed by Lexie Corner Researchers at the National University of Singapore (NUS) have created a novel design idea for next-generation carbon-based quantum materials in the form of a small magnetic ...
The Latest Google Headlines on:
Nanoscale sensors
[google_news title=”” keyword=”Nanoscale sensors” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Drug production
- AI Supercharges Fentanyl Production And Distribution, Study Findson April 27, 2024 at 4:00 am
One need not be a world leader in AI-assisted pharmacology to start illicit drug production. You simply need to understand the key precursor chemicals, AI and synthesize.
- Limestone Correctional warden due in court May 7 on drug chargeson April 26, 2024 at 4:16 pm
More information about the multi-count drug arrest of the warden of Limestone Correctional Facility has been released, court documents show.
- Scientists discover a new signaling pathway and design a novel drug for liver fibrosison April 26, 2024 at 9:25 am
A healthy liver filters all the blood in your body, breaks down toxins and digests fats. It produces collagen to repair damaged cells when the liver is injured. However, a liver can produce too much ...
- Drug Shortages Compounded by Lack of Information, Transparencyon April 26, 2024 at 6:30 am
A lack of information on drug shortages can make it difficult to identify and respond to shortages appropriately, but improving supply chain transparency and federal oversight could reduce or prevent ...
- Why the obesity drug market is about to get a lot more crowdedon April 26, 2024 at 6:15 am
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
- Mexico’s chief detective apologizes for saying his country is the ‘champion’ of fentanyl productionon April 25, 2024 at 5:13 pm
The head of Mexico’s detective service has apologized for saying his country is “the champion” of fentanyl and meth production.
- A Proven Model to Combat U.S. Drug Shortageson April 25, 2024 at 5:05 am
Drug shortages continue to plague the United States. In many ways, the problem is the result of deficiencies in the current pharma market. But a model for addressing this problem is showing that it ...
- Shortages of generic drugs can’t be blamed solely on group purchasing organizationson April 25, 2024 at 1:31 am
The dominance of group purchasing organizations (GPOs) is often cited as a cause of generic drug shortages. The problem is more complicated than that.
- Malaria is still killing people in Kenya, but a vaccine and local drug production may helpon April 25, 2024 at 12:17 am
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may help.
- New method could cut waste from drug productionon April 24, 2024 at 10:37 am
Scientists have developed a sustainable new way of making complex molecules, which could greatly reduce waste produced during drug manufacturing, a study suggests.
The Latest Google Headlines on:
Drug production
[google_news title=”” keyword=”drug production” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]